FDA Adverse Event Injury Summary report: N

M2A-MAGNUM PF CUP 50ODX44ID

MDR report key: 6842156 · Received September 5, 2017

Report

Report Number
0001825034-2017-06586
Event Type
Injury
Date Received
September 5, 2017
Date of Event
October 14, 2015
Report Date
December 1, 2017
Manufacturer
ZIMMER BIOMET, INC.
Product Code
KWA
PMA / PMN Number
PK042037
Removal / Correction Number
N/A
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CO, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. CONCOMITANT PRODUCT - STRYKER ADM ARTICULATING INSERT. REPORTED EVENT WAS ABLE TO BE CONFIRMED VIA REVISION OPERATIVE NOTES. DEVICE HISTORY RECORD (DHR) WAS REVIEWED AND NO DISCREPANCIES WERE FOUND. ROOT CAUSE WAS UNABLE TO BE DETERMINED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Additional Manufacturer Narrative · 1

(B)(4). CUSTOMER HAS INDICATED THAT THE PRODUCT WILL NOT BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED. CONCOMITANT PRODUCTS: 650-1055, BIOLOX DELTA HEAD, 815430, 650-1065, CER OPTION TYPE 1 TPR SLEVE -3, 540630, X180307, BI-METRIC/X POR NC 7X115, 222780. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 0001825034 - 2017 - 06585.

Description of Event or Problem · 1

IT WAS REPORTED THAT PATIENT UNDERWENT A REVISION PROCEDURE APPROXIMATELY THREE MONTHS POST-IMPLANTATION DUE TO INSTABILITY. DURING THE PROCEDURE, FLUID IN THE BURSAL AREA WAS NOTED. THE FEMORAL HEAD, ACETABULAR CUP AND COMPETITOR BEARING WERE REMOVED AND REPLACED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
621521 M2A-MAGNUM PF CUP 50ODX44ID PROSTHESIS, HIP KWA ZIMMER BIOMET, INC. N/A 956660

Patients

Seq Age Sex Outcome Treatment
1 49 YR Hospitalization| R